Cyclo Therapeutics to Present at the World Orphan Drug Congress USA 2022

Author's Avatar
Jul 11, 2022

Cyclo+Therapeutics%2C+Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced that Lise Kjems, MD, PhD, Chief Medical Officer of Cyclo Therapeutics will present at the World+Orphan+Drug+Congress+USA+2022 being held July 11-13, 2022 in Boston, MA.